Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Neurocrine Biosciences, Inc.”

110 pharma patents match "Neurocrine Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 110
Index total 30,257
Page 4 / 5

Quick answer

This filtered view shows 110 pharmaceutical patents matching "Neurocrine Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

110 results for “Neurocrine Biosciences, Inc.” · 30,257 patents in full index Clear search

  1. US 6939883

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Sep 6, 2005 · Expires Sep 1, 2025

    expired
  2. US 6933274

    Methods for treatment of diabetes using a peptide analogues of insulin

    Neurocrine Biosciences, Inc. · Granted Aug 23, 2005 · Expires Aug 18, 2025

    expired
  3. US 6921761

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 26, 2005 · Expires Jul 21, 2025

    expired
  4. US 6903106

    Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Jun 7, 2005 · Expires Jun 2, 2025

    expired
  5. US 6872728

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Mar 29, 2005 · Expires Mar 24, 2025

    expired
  6. US 6750350

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jun 15, 2004 · Expires Jun 10, 2024

    expired
  7. US 6747034

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jun 8, 2004 · Expires Jun 3, 2024

    expired
  8. US 6740638

    Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein

    Neurocrine Biosciences, Inc. · Granted May 25, 2004 · Expires May 20, 2024

    expired
  9. US 6740656

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted May 25, 2004 · Expires May 20, 2024

    expired
  10. US 6723841

    Corticotropin-releasing factor2 receptors

    Neurocrine Biosciences, Inc. · Granted Apr 20, 2004 · Expires Apr 15, 2024

    expired
  11. US 6723721

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Apr 20, 2004 · Expires Apr 15, 2024

    expired
  12. US 6677340

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jan 13, 2004 · Expires Jan 8, 2024

    expired
  13. US 6673796

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jan 6, 2004 · Expires Jan 1, 2024

    expired
  14. US 6608197

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Aug 19, 2003 · Expires Aug 14, 2023

    expired
  15. US 6583143

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jun 24, 2003 · Expires Jun 19, 2023

    expired
  16. US 6562942

    Methods for treatment of diabetes using peptide analogues of insulin

    Neurocrine Biosciences, Inc. · Granted May 13, 2003 · Expires May 8, 2023

    expired
  17. US 6544999

    Polymorphs of N-methyl-N-(3-{3-[2- thienylcarbonyl]-pyrazol-[1,5-&agr;]- pyrimidin-9-yl}phenyl)acetamide and compositions and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Apr 8, 2003 · Expires Apr 3, 2023

    expired
  18. US 6541469

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Apr 1, 2003 · Expires Mar 27, 2023

    expired
  19. US 6537998

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Mar 25, 2003 · Expires Mar 20, 2023

    expired
  20. US 6531475

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Mar 11, 2003 · Expires Mar 6, 2023

    expired
  21. US 6514982

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Feb 4, 2003 · Expires Jan 30, 2023

    expired
  22. US 6500839

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Dec 31, 2002 · Expires Dec 26, 2022

    expired
  23. US 6489299

    Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein

    Neurocrine Biosciences, Inc. · Granted Dec 3, 2002 · Expires Nov 28, 2022

    expired
  24. US 6485746

    Controlled-release sedative-hypnotic compositions and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Nov 26, 2002 · Expires Nov 21, 2022

    expired